CenSyn is a pre-FDA stage medical device company that creates a handheld EEG monitoring device for accelerated screening of Alzheimer's, Traumatic Brain Injury and Epilepsy. We strive to meet unmet needs in the field of clinical neurology. Our value proposition is to make brain health data accessible anytime, anywhere to clinicians for early screening of neurological conditions, reducing healthcare costs through improved patient outcomes. We have prototyped an end-to-end device that can acquire and display EEG signals in less than a minute including software integrations for remote brain/tele-neurology monitoring. We are currently conducting a 50 patient validation study to test efficacy of the device. Through this initiative, we are building our own proprietary EEG database for Artificial Intelligence value creation opportunities. Connect and join us on our journey!